melanoma Archive — Page 1 of 3

A bald man wearing glasses and a yellow shirt sits in a teal armchair, embracing two black-and-white dogs in a living room.
October 28, 2026

More time with the people he loves: A veteran tells his TIL therapy story, a first at Vanderbilt-Ingram Cancer Center

Senior Chief Petty Officer Ed Stift, U.S. Navy (retired), was the first patient to receive tumor-infiltrating lymphocyte (TIL) therapy at Vanderbilt-Ingram Cancer Center. Watch his story.

Two men pose indoors: one in a dark suit and red tie, and one wearing glasses and a white University of Tennessee medical coat labeled “Douglas Johnson, MD, MSCI, Hematology-Oncology.”
June 15, 2026

New Therapy

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

By Tom Wilemon
Thermometer beside a yellow sunscreen bottle and a blue towel, suggesting hot weather and sun protection.
May 21, 2026

Protect your skin: What to know about melanoma and Mohs surgery at Vanderbilt Health 

A vast majority of melanoma cases are linked to ultraviolet exposure from sunlight, making it largely preventable. Risk factors include fair skin, a history of sunburns (especially in childhood), numerous moles, and a family history of melanoma.

By Paul Govern
Tennis racket resting on a court with a yellow tennis ball caught against its strings.
December 19, 2023

Melanoma, anyone?

Collegiate tennis and golf athletes aren’t using enough sunscreen according to a recent survey; meanwhile, the deadly skin cancer melanoma is on the rise.

By Paul Govern
Portrait of a smiling man wearing glasses, a white medical coat, and a tie with a small awareness ribbon pin.
August 8, 2023

Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

By Tom Wilemon
Research by Ann Richmond, PhD, second from left, Chi Yan, PhD, left, Kensey Bergdorf, PhD, JinMing Yang, PhD, and colleagues is leading to new insights on melanoma tumor formation and growth.
June 29, 2023

Study identifies key regulator of melanoma development

Vanderbilt investigators have revealed the mechanisms by which the chemokine receptor CXCR2, is associated with melanoma tumor formation and growth — a discovery that supports the continued development of drugs that inhibit the receptor’s activity.

By Tom Wilemon